DE69130679D1 - Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation - Google Patents

Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation

Info

Publication number
DE69130679D1
DE69130679D1 DE69130679T DE69130679T DE69130679D1 DE 69130679 D1 DE69130679 D1 DE 69130679D1 DE 69130679 T DE69130679 T DE 69130679T DE 69130679 T DE69130679 T DE 69130679T DE 69130679 D1 DE69130679 D1 DE 69130679D1
Authority
DE
Germany
Prior art keywords
treatment
cell proliferation
compositions
diseases
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69130679T
Other languages
English (en)
Other versions
DE69130679T2 (de
Inventor
Lawrence Blatt
Milton Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DE69130679D1 publication Critical patent/DE69130679D1/de
Publication of DE69130679T2 publication Critical patent/DE69130679T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69130679T 1990-10-17 1991-10-15 Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation Expired - Lifetime DE69130679T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59920690A 1990-10-17 1990-10-17
US77292291A 1991-10-15 1991-10-15
PCT/US1991/007722 WO1992006707A1 (en) 1990-10-17 1991-10-15 Methods and compositions for the treatment of cell proliferation disorders

Publications (2)

Publication Number Publication Date
DE69130679D1 true DE69130679D1 (de) 1999-02-04
DE69130679T2 DE69130679T2 (de) 1999-05-06

Family

ID=27083273

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69130679T Expired - Lifetime DE69130679T2 (de) 1990-10-17 1991-10-15 Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation

Country Status (17)

Country Link
EP (1) EP0553294B1 (de)
JP (1) JP3496937B2 (de)
CN (1) CN1053117C (de)
AT (1) ATE174798T1 (de)
AU (1) AU660633B2 (de)
CA (1) CA2094275C (de)
DE (1) DE69130679T2 (de)
DK (1) DK0553294T3 (de)
ES (1) ES2128348T3 (de)
HK (1) HK1010340A1 (de)
IE (1) IE913656A1 (de)
IL (1) IL99778A (de)
NO (1) NO931413L (de)
NZ (1) NZ240264A (de)
PT (1) PT99265B (de)
SG (1) SG52537A1 (de)
WO (1) WO1992006707A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US5372808A (en) * 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
WO1995015177A2 (en) * 1993-12-02 1995-06-08 President And Fellows Of Harvard College Improved efficacy of alpha-helical cytokines
US20030053982A1 (en) 1994-09-26 2003-03-20 Kinstler Olaf B. N-terminally chemically modified protein compositions and methods
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5824789A (en) * 1995-06-07 1998-10-20 Systemix, Inc. Human growth factors, nucleotide sequence encoding growth factors, and method of use thereof
US6013253A (en) * 1997-08-15 2000-01-11 Amgen, Inc. Treatment of multiple sclerosis using consensus interferon and IL-1 receptor antagonist
US7314613B2 (en) 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
US7232805B2 (en) * 2003-09-10 2007-06-19 Inflabloc Pharmaceuticals, Inc. Cobalamin conjugates for anti-tumor therapy
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
CA2566247A1 (en) 2004-05-19 2005-12-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
CA2597317C (en) * 2005-03-09 2018-01-02 Guangwen Wei Uses of recombinant super-compound interferons
MX2007014524A (es) 2005-05-18 2008-02-07 Maxygen Inc Polipeptidos desarrollados de interferon-alfa.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US4879471A (en) * 1987-03-25 1989-11-07 Measurex Corporation Rapid-scanning infrared sensor

Also Published As

Publication number Publication date
DK0553294T3 (da) 1999-08-23
IE913656A1 (en) 1992-04-22
IL99778A (en) 1996-11-14
HK1010340A1 (en) 1999-06-17
DE69130679T2 (de) 1999-05-06
SG52537A1 (en) 1998-09-28
EP0553294B1 (de) 1998-12-23
EP0553294A1 (de) 1993-08-04
IL99778A0 (en) 1993-02-21
PT99265B (pt) 1999-04-30
ES2128348T3 (es) 1999-05-16
CA2094275C (en) 2003-06-03
WO1992006707A1 (en) 1992-04-30
NO931413D0 (no) 1993-04-16
CN1053117C (zh) 2000-06-07
ATE174798T1 (de) 1999-01-15
CN1064018A (zh) 1992-09-02
PT99265A (pt) 1992-08-31
NO931413L (no) 1993-04-16
AU9023591A (en) 1992-05-20
EP0553294A4 (en) 1994-11-23
CA2094275A1 (en) 1992-04-18
JPH06502426A (ja) 1994-03-17
NZ240264A (en) 1997-07-27
AU660633B2 (en) 1995-07-06
JP3496937B2 (ja) 2004-02-16

Similar Documents

Publication Publication Date Title
FI904204A0 (fi) Foerfarande foer framstaellning av cykliska aminosyraderivat och mellanprodukter.
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
DE10199020I1 (de) Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit
FI20115753A (fi) Farmaseuttisia koostumuksia IL-6:n tuoton aiheuttamien sairauksien hoitoon
DE69124293D1 (de) Vorrichtung zur Behandlung von Wirbelsäulenerkrankungen
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE69130679D1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
DE3873855D1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.
ATE269077T1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
DE3583220D1 (de) Verwendung von dipeptidderivaten fuer die herstellung von arzneimitteln zur behandlung von an amyotropher lateralsklerose erkrankten.
FI922770A (fi) Bcrf1-proteinerna som inhibitorer av y-interferon.
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
ATE11013T1 (de) Heilmittelzusammensetzungen zur behandlung der haut.
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
ES2128313T3 (es) Naftalimidas n-substituidas, su obtencion y empleo.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
DE3578374D1 (de) Verwendung von chinolonen fuer die herstellung eines arzneimittels zur behandlung von herzerkrankungen.
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
DE3280419D1 (de) Medizinisches praeparat zur behandlung von hautleiden.
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus
ITMI911206A0 (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari

Legal Events

Date Code Title Description
8364 No opposition during term of opposition